Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Astex Pharma Announces It Will Halt Development of Lung Cancer Drug | |
|
| |
Astex Pharmaceuticals Inc has confirmed that it will be halting the development of experimental small-cell lung cancer drug, Amuvatinib. The reason is that the drug failed to achieve a high response rate on an ongoing study.
The main goal of the trial, known as ESCAPE, was to evaluate if the drug achieved a response rate of 10 percent. However Amuvatinib was able to achieve a rate of only 9.5 percent.
The company said in a statement that no new safety issues were identified during the trial and that it would license the drug to any other companies interested in developing it further.
Source-Medindia
| |
|
|
More News on: Drug Toxicity, Lung Biopsy, Lung Cancer, Malignant Mesothelioma, Cancer and Homeopathy, Smoking Risk, Signature Drug Toxicity, Cancer Facts, Asbestosis , Cancer
 Comment & Contribute
|
Related Links
Lung Cancer
Lung cancer is the uncontrolled growth of abnormal cells in the lung. Majority of people who get lung cancer have been cigarette smokers, but not all ...
Lung Cancer Screening
Lung cancer accounts for nearly 1.3 million deaths annually worldwide. Lung cancer screening can help in early detection of cancer and possible ...
Mesothelioma - Animation
Animation on mesothelioma - a form of lung cancer, that explains about the condition, its risk factors, diagnosis and ...
Corporate Related News
Esperion Therapeutics Has Raised $33 Million to Finance Clinical Trials
American biotech company Esperion Therapeutics revealed that it has managed to raise $33 million through preferred stock financing which will be used ...
Phase 1 Clinical Trial Reveals Positive Data for BIND Theraputics' Drug for Solid Tumors
Presenting the data at the American Association for Cancer Research (AACR) 2013 Annual Meeting, biopharmaceutical company BIND Therapeutics revealed ...
Cancer Breakthrough Reported by Novogen
Australian drug company Novogen Limited revealed that it has succeeded in isolating the most potent form of its lead anti-cancer drug candidate, ...
Opto Circuits Agrees to Sell Diagnostic Cardiology Products to Mortara Instrument
Mortara Instrument Inc. of Milwaukee has signed an agreement to acquire the cardiac diagnostic product line from Cardiac Science, which is a part of ...
Panacea to Supply Polio Vaccines to Central Government
New Delhi based pharmaceutical company Panacea Biotec revealed that it has signed a deal with the central government to supply more than 345 million ...
Following Pharma Deal, Nestle Ventures into Chinese Medicine
Nestle has announced that it is moving into traditional Chinese medicine by joining forces with Chinese pharma group Chi-Med. The new ...
Medwonders Health Network
- Health News Index
 | Quiz on Cancer Looking for information on cancer? Go through medindia's Cancer quiz. 
|
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
Cancer
Complete Medindia Resources
|
| News Categories: |
| » | Health Campaigners Hail Brave Angelina Jolie's Mastectomy Revelation |
| » | Angelina Jolie's Breast Removal Surgery Boosts Cancer Awareness, Experts Advise Caution |
| » | Shakira Having Sleepless Nights During Pregnancy |
| » | Belgian Nobel Laureate Christian De Duve Dies |
| » | Sherri Shepherd Owes Her Life to Diabetes |
| More Celebrity News | |
|
Ask an Expert
